Dermatitis
📧 Sign up to get email alerts when something new happens for Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants [NA]
A completed, single-center exploratory trial investigated how exposure to surfactants alters skin microflora in individuals with dermatitis.
-
FDA approval · 2016-08-05FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the Original Application (ANDA) for Triamcinolone Acetonide, a generic product manufactured by Glenmark Pharmaceuticals Inc., U…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY [Phase 1, Phase 2]
This is an update on a Phase 1/2 clinical trial evaluating Mary Duol Repair Balm to prevent or reduce skin toxicity caused by antineoplastic…
-
FDA approval · 2016-07-28FDA Approved: PSORCON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for PSORCON (diflorasone diacetate) filed by Sun Pharmaceutical Industries, likely updating labeling…
-
FDA approval · 2016-07-22FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's generic Triamcinolone Acetonide under Original Application (ANDA 206379) for topical corticosteroid use in inflammat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-06-23FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic Nystatin and Triamcinolone Acetonide topical ointment (ANDA 208300) for the treatment of cutaneous candidias…
-
FDA approval · 2016-06-08FDA Approved: DESONIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for DESONIDE submitted by Padagis Israel Pharmaceuticals Ltd, resulting in labeling changes for …
-
FDA approval · 2016-05-19FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' fluocinonide acetonide topical product through an original generic application (ANDA).
-
FDA approval · 2016-05-19FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' fluocinonide acetonide topical product as an original application (ANDA 202368). The generic top…
-
FDA approval · 2016-05-10FDA Approved: DESOXIMETASONE — Original Application (Novel Laboratories, Inc.)
FDA approves a generic topical desoximetasone from Novel Laboratories, Inc. under an Original Application (ANDA 206792).
-
FDA approval · 2015-11-23FDA Approved: CLOBETASOL PROPIONATE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' generic clobetasol propionate topical product under an Original Application (ANDA 206075).
-
FDA approval · 2015-11-06FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for desoximetasone by Sun Pharmaceutical Industries, enabling changes to the product's labeling …
-
FDA approval · 2015-09-02FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved the original application for a generic fluocinonide acetonide topical product by Lupin Pharmaceuticals (ANDA 206422).
-
FDA label_change · 2015-06-29FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for clobetasol propionate from Actavis Pharma, Inc. to update the product labeling.
-
FDA approval · 2015-06-16FDA Approved: DESONIDE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for desonide submitted by Cosette Pharmaceuticals, Inc.
-
FDA label_change · 2015-05-21FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases. [EARLY_Phase 1]
A Phase 1 trial comparing narrowband UVB and PUVA therapies for dermatitis and psoriasis was terminated.
-
FDA approval · 2015-04-20FDA Approved: DESOXIMETASONE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the original application for desoximetasone from Padagis Israel Pharmaceuticals Ltd, granting approval for a topical corticoste…
-
FDA approval · 2015-04-15FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for desoximetasone submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-04-13FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Triamcinolone Acetonide via an Original Application (ANDA) for Padagis Israel Pharmaceuticals Ltd., authorizing a generic corti…
-
FDA approval · 2015-01-22FDA Approved: HYDROCORTISONE — Supplemental Application (Allegis Holdings LLC)
FDA approved a supplemental application for HYDROCORTISONE lotion from Allegis Holdings LLC.
-
FDA approval · 2015-01-20FDA Approved: BETAMETHASONE VALERATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone valerate from E. Fougera & Co., a division of Fougera Pharmaceuticals, LLC. Th…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202) [Phase 3]
Phase 3 efficacy and safety results for desloratadine (MK-4117) in Japanese participants with eczema/dermatitis and dermal pruritus have bee…
-
FDA approval · 2014-10-30FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for hydrocortisone butyrate from Oceanside Pharmaceuticals, expanding its regulatory status under ND…
-
FDA label_change · 2014-10-30FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for hydrocortisone butyrate from Oceanside Pharmaceuticals, resulting in changes to the product labe…